anti-tau antisense oligonucleotides (Washington University in St Louis/Ionis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-tau antisense oligonucleotides (Washington University in St Louis/Ionis)
Drug Alias Nameanti-tau antisense oligonucleotides (Washington University in St Louis/Isis Pharmaceuticals)ASO-12
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington UniversityIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A